BIO LAB NATURALS, INC. (BLAB) financial statements (2022 and earlier)
Company profile
| Business Address |
7400 E. CRESTLINE CIRCLE GREENWOOD VILLAGE, CO 80111 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| SIC | 799 - Miscellaneous Amusement And Recreation (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2021 | 12/31/2020 | |||
|---|---|---|---|---|
| ASSETS | ||||
| Current Assets | ||||
| Cash, cash equivalents, and short-term investments | 4 | 69 | ||
| Cash and cash equivalents | 4 | 69 | ||
| Prepaid expense | 12 | |||
| Deposits current assets | 10 | |||
| Other current assets | 2 | |||
| Other undisclosed current assets | 107 | |||
| Total current assets: | 126 | 79 | ||
| Noncurrent Assets | ||||
| Property, plant and equipment | 54 | 168 | ||
| Total noncurrent assets: | 54 | 168 | ||
| TOTAL ASSETS: | 180 | 247 | ||
| LIABILITIES AND EQUITY | ||||
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 57 | 17 | ||
| Accounts payable | 57 | 17 | ||
| Debt | 35 | |||
| Due to related parties | 30 | |||
| Total current liabilities: | 122 | 17 | ||
| Noncurrent Liabilities | ||||
| Total liabilities: | 122 | 17 | ||
| Stockholders' equity | ||||
| Stockholders' equity attributable to parent | 58 | 230 | ||
| Preferred stock | 0 | 0 | ||
| Common stock | 1 | 1 | ||
| Additional paid in capital | 35,750 | 35,672 | ||
| Accumulated deficit | (35,693) | (35,444) | ||
| Total stockholders' equity: | 58 | 230 | ||
| TOTAL LIABILITIES AND EQUITY: | 180 | 247 | ||
Income statement (P&L) ($ in thousands)
| 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|
| Revenues | 339 | 21 | |
| Cost of revenue | (274) | (79) | |
| Cost of goods and services sold | (236) | ||
| Other cost of operating revenue | (16) | (43) | |
| Gross profit: | 65 | (58) | |
| Operating expenses | (239) | (218) | |
| Operating loss: | (174) | (276) | |
| Nonoperating expense | (75) | (0) | |
| Interest and debt expense | (3) | (0) | |
| Other undisclosed income from continuing operations before equity method investments, income taxes | 0 | ||
| Loss from continuing operations before equity method investments, income taxes: | (252) | (276) | |
| Other undisclosed income from continuing operations before income taxes | 3 | ||
| Net loss available to common stockholders, diluted: | (249) | (276) | |
Comprehensive Income ($ in thousands)
| 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|
| Net loss: | (249) | (276) | |
| Comprehensive loss, net of tax, attributable to parent: | (249) | (276) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.